Back

Role of smooth muscle-derived S100A4 in an atherosclerotic mouse model

26 August 2022 (17:05 - 17:15)
Organised by:
Congress Presentation Part of: Atherosclerosis: new mechanisms and therapeutic targets Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Luis Miguel Cardoso dos Santos

Karolinska Institute, Stockholm (Sweden)

2 More presentations in this session

Presentation thumbnail
GPR55 deficiency in B-cells promotes atherosclerosis and regulates plasma cell maturation
Doctor R. Guillamat-Prats (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Macrophage-specific deletion of neuropilin-2 inhibits inflammatory signalling and attenuates atherosclerotic plaque development in apolipoprotein e-deficient mice
Doctor J. Fernando-Sayers (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Atherosclerosis: new mechanisms and therapeutic targets

The Event

Event poster

ESC Congress 2022

26 August 2022 17:05 CET
You may be interested in
thumbnail
Congress Presentation
Smooth muscle cell-specific deletion of S100A4 modifies smooth muscle cell fate and inflammation in murine atherosclerotic lesions
thumbnail
Webinar
Inflammation in cardiovascular disease and classification of human atherosclerotic plaques according to underlying biology and clinical presentation
thumbnail
Congress Session
Novel mechanisms for insights into atherosclerosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources